# AKEBIA THREAPEUTICS INC (AKBA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AKBA/

- Reporting holders: 3
- Reported value: $22.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Legacy Private Trust Co.](https://holderbook.com/funds/1352547-legacy-private-trust-co/) | $11.3K | 12,250 | 0.0% | 11 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $6.1K | 6,614 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $5.0K | 5,422 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $22.3K |
| Q2 2026 | 173 | $138.1M |
| Q1 2026 | 170 | $143.0M |
| Q4 2025 | 166 | $192.0M |
| Q3 2025 | 178 | $344.7M |
| Q2 2025 | 160 | $398.0M |
| Q1 2025 | 143 | $184.6M |
| Q4 2024 | 123 | $130.5M |
| Q3 2024 | 116 | $80.0M |
| Q2 2024 | 105 | $59.1M |
| Q1 2024 | 120 | $112.1M |
| Q4 2023 | 87 | $70.5M |